Thermo Fisher Scientific Q4 FY25: where the revenue came from and where it went
The whole income statement of Thermo Fisher Scientific for this quarter, as one diagram: what earned the revenue, and what it went on.
- Period
- Sep 28 – Dec 31, 2025
- Reported
- Feb 26, 2026
Revenue$12.22B
+7% year over year
Gross profit$4.96B
41% margin
Operating profit$2.26B
18% margin
Net profit$1.98B
16% margin
The numbers
| Item | Value | Share of revenue | Year over year |
|---|---|---|---|
| Revenue | 12.22 | 100% | +7% |
| Consumables | 5.03 | 41% | +11% |
| Services | 4.97 | 41% | +7% |
| Instruments | 2.22 | 18% | −1% |
| Cost of revenue | −7.25 | 59% | |
| Gross profit | 4.96 | 41% margin | +0pp |
| R&D | −0.36 | 3% | +0pp |
| SG&A | −2.35 | 19% | +0pp |
| Operating profit | 2.26 | 18% margin | +1pp |
| Interest & other costs | −0.12 | ||
| Tax | −0.15 | ||
| Net profit | 1.98 | 16% margin | +0pp |
214 of 418 companies, most recently reported first
New results in your inbox
When a big company reports, we send you a link to its diagram before anyone has time to comment on it. This is a mailing list, not an account: it does not open the diagrams by itself. No spam, one-click unsubscribe.
Drag or use the arrow keys to see the rest